Smith Hunter C — SEC insider filings

SEC reporting owner CIK 1636385. 38 insider filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2021-01-20 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RHYTHM PHARMACEUTICALS, INC. (RYTM)Chief Financial Officer35—52 legs · 264,917 sh · $19,418,08474
Aeglea BioTherapeutics, Inc. (AGLE)Director3——3

Insider filings — Smith Hunter C

FiledFormIssuerReported transactionsSource
2026-09-014RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 57,187 @ $25.79 · Sale (S): 23,072 @ $104.59 · Sale (S): 11,514 @ $105.37 · Sale (S): 28,188 @ $106.20 · Option exercise (M): 57,187 (derivative) @ $0EDGAR
2026-05-204RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 3,000 @ $17.87 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-03-024RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 6,099 @ $6.80 · Option exercise (M): 6,099 (derivative) @ $0EDGAR
2026-02-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 1,200 @ $99.42 · Sale (S): 200 @ $100.52 · Sale (S): 900 @ $101.70 · Sale (S): 1,069 @ $103.00 · Sale (S): 200 @ $103.84 · Sale (S): 1,308 @ $100.27 · +3 moreEDGAR
2026-02-124RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 1,913 @ $102.66 · Sale (S): 700 @ $103.68 · Sale (S): 100 @ $104.76 · Sale (S): 2,266 @ $98.37 · Sale (S): 400 @ $99.44 · Sale (S): 100 @ $100.85 · +6 moreEDGAR
2026-02-064RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 1,500 @ $104.74 · Sale (S): 1,000 @ $106.60 · Sale (S): 747 @ $107.67 · Sale (S): 3,381 @ $106.06EDGAR
2026-02-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 26,000 · Tax withholding (F): 10,750 @ $108.99 · Option exercise (M): 4,062 (derivative) @ $0 · Option exercise (M): 4,925 (derivative) @ $0 · Option exercise (M): 6,600 (derivative) @ $0 · Option exercise (M): 10,413 (derivative) @ $0EDGAR
2025-08-144RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 24,611 @ $6.88 · Sale (S): 24,611 @ $96.33 · Option exercise (M): 3,477 @ $6.88 · Sale (S): 3,477 @ $96 · Option exercise (M): 24,611 (derivative) @ $0 · Option exercise (M): 3,477 (derivative) @ $0EDGAR
2025-07-114RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 42,120 @ $6.88 · Sale (S): 17,113 @ $75.38 · Sale (S): 1,607 @ $76.17 · Sale (S): 23,400 @ $84.50 · Option exercise (M): 42,120 (derivative) @ $0EDGAR
2025-07-084RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 6,986 @ $6.88 · Option exercise (M): 6,986 (derivative) @ $0EDGAR
2025-06-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 23,400 @ $6.88 · Sale (S): 4,407 @ $60.93 · Sale (S): 18,993 @ $61.52 · Option exercise (M): 23,400 (derivative) @ $0EDGAR
2025-02-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 6,600 · Sale (S): 2,215 @ $57.22 · Grant/award (A): 41,650 (derivative) @ $0 · Grant/award (A): 62,500 (derivative) @ $0 · Option exercise (M): 6,600 (derivative) @ $0EDGAR
2025-02-144RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 739 @ $56.39 · Sale (S): 12 @ $56.22EDGAR
2025-02-114RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,062 · Option exercise (M): 2,343 · Sale (S): 1,291 @ $57.51 · Sale (S): 5 @ $57.53 · Option exercise (M): 4,062 (derivative) @ $0 · Option exercise (M): 2,343 (derivative) @ $0EDGAR
2025-02-044RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,925 · Sale (S): 1,678 @ $59.43 · Option exercise (M): 4,925 (derivative) @ $0EDGAR
2024-03-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 15,515 @ $39.22EDGAR
2024-02-214RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 33,750 @ $0 · Grant/award (A): 26,400 (derivative) @ $0 · Grant/award (A): 80,400 (derivative) @ $0EDGAR
2024-02-134RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,063 · Option exercise (M): 2,344 · Sale (S): 1,209 @ $51.38 · Sale (S): 709 @ $49.82 · Option exercise (M): 4,063 (derivative) @ $0 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-02-054RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,925 · Sale (S): 1,616 @ $45.06 · Option exercise (M): 4,925 (derivative) @ $0EDGAR
2024-01-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 10,500 @ $6.88 · Option exercise (M): 10,500 (derivative) @ $0EDGAR
2023-12-074RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 7,026 @ $6.88 · Sale (S): 7,026 @ $35.06 · Option exercise (M): 20,000 @ $6.88 · Sale (S): 20,000 @ $40 · Option exercise (M): 7,026 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2023-11-284RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 10,974 @ $6.88 · Sale (S): 10,974 @ $35.02 · Option exercise (M): 10,974 (derivative) @ $0EDGAR
2023-11-164RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 12,000 @ $6.88 · Sale (S): 12,000 @ $30.38 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2023-06-304Aeglea BioTherapeutics, Inc. (AGLE)Grant/award (A): 1,950,000 (derivative) @ $0EDGAR
2023-06-214RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 2,000 @ $6.88 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2023-02-144/ARHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 1,413 @ $27.51EDGAR
2023-02-144RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 2,344 · Sale (S): 702 @ $26.87 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2023-02-134RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,063 · Sale (S): 1,398 @ $27.66 · Option exercise (M): 4,063 (derivative) @ $0EDGAR
2023-02-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 19,700 (derivative) @ $0 · Grant/award (A): 53,600 (derivative) @ $0EDGAR
2022-12-294RHYTHM PHARMACEUTICALS, INC. (RYTM)Gift (G): 2,500 @ $0EDGAR
2022-07-064RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 25,000 · Sale (S): 7,547 @ $4.08 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2022-06-094Aeglea BioTherapeutics, Inc. (AGLE)Grant/award (A): 43,000 (derivative) @ $0EDGAR
2022-02-154RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 2,344 · Sale (S): 833 @ $6.10 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2022-02-114RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 16,250 (derivative) @ $0 · Grant/award (A): 97,500 (derivative) @ $0EDGAR
2021-11-164Aeglea BioTherapeutics, Inc. (AGLE)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2021-04-234RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 5,000 @ $6.88 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-02-164RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 9,375 (derivative) @ $0 · Grant/award (A): 56,250 (derivative) @ $0EDGAR
2021-01-204RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,000 @ $6.88 · Option exercise (M): 4,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs